Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Public ClinicalTrials.gov record NCT02260492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Study identification
- NCT ID
- NCT02260492
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Oriel Therapeutics
- Industry
- Enrollment
- 879 participants
Conditions and interventions
Conditions
Interventions
- OT329 (combination of fluticasone propionate and salmeterol xinafoate) Drug
- Advair Diskus (combination of fluticasone propionate and salmeterol xinafoate) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Apr 30, 2015
- Completion
- Jun 30, 2015
- Last update posted
- Jun 14, 2017
2014 – 2015
United States locations
- U.S. sites
- 47
- U.S. states
- 22
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oriel Investigative Site | Goodyear | Arizona | 85395 | — |
| Oriel Investigative Site | Tempe | Arizona | 85283 | — |
| Oriel Investigative Site | Anaheim | California | 92801 | — |
| Oriel Investigative Site | Los Angeles | California | 90017 | — |
| Oriel Invetigative Site | Los Angeles | California | 90048 | — |
| Oriel Investigative Site | Mission Viejo | California | 92691 | — |
| Oriel Investigative Site | Centennial | Colorado | 80112 | — |
| Oriel Investigative Site | Clearwater | Florida | 33756 | — |
| Oriel Investigative Site | Coral Gables | Florida | 33134 | — |
| Oriel Investigative Site | Homestead | Florida | 33030 | — |
| Oriel Investigative Site | Jupiter | Florida | 33458 | — |
| Oriel Investigative Site | Kissimee | Florida | 34741 | — |
| Oriel Investigative Site | Miami | Florida | 33165 | — |
| Oriel Investigative Site | New Port Richie | Florida | 34652 | — |
| Oriel Investigative Site | Orlando | Florida | 32806 | — |
| Oriel Investigative Site | Tallahassee | Florida | 32308 | — |
| Oriel Investigative Site | Lawrenceville | Georgia | 30046 | — |
| Oriel Investigative Site | Iowa City | Iowa | 52240 | — |
| Oriel Investigative Site | North Dartmouth | Massachusetts | 02747 | — |
| Oriel Therapeutics Site | Minneapolis | Minnesota | 55402 | — |
| Oriel Investigative Site | St Louis | Missouri | 63141 | — |
| Oriel Investigative Site | Bellevue | Nebraska | 68123 | — |
| Oriel Investigative Site | Omaha | Nebraska | 68114 | — |
| Oriel Investigative Site | Skillman | New Jersey | 08558 | — |
| Oriel Investigative Site | Albuquerque | New Mexico | 87108 | — |
| Oriel Investigative Site | New York | New York | 10018 | — |
| Oriel Investigative Site | Charlotte | North Carolina | 28277 | — |
| Oriel Investigative Site | Raleigh | North Carolina | 27607 | — |
| Oriel Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Oriel Investigative Site | Cincinnati | Ohio | 45231 | — |
| Oriel Investigative Site | Cincinnati | Ohio | 45242 | — |
| Oriel Investigative Site | Middleburg Heights | Ohio | 44130 | — |
| Oriel Investigative Site | Toledo | Ohio | 43617 | — |
| Oriel Investigative Site | Oklahoma City | Oklahoma | 73120 | — |
| Oriel Investigative Site | Eugene | Oregon | 97401 | — |
| Oriel Investigative Site | Medford | Oregon | 97504 | — |
| Oriel Investigative Site | Portland | Oregon | 97202 | — |
| Oriel Investigative Site | Providence | Rhode Island | 02906 | — |
| Oriel Investigative Site | Warwick | Rhode Island | 02886 | — |
| Oriel Investigative Site | Rock Hill | South Carolina | 29732 | — |
| Oriel Investigative Site | Austin | Texas | 78750 | — |
| Oriel Investigative Site | Austin | Texas | 78756 | — |
| Oriel Investigative Site | Houston | Texas | 77055 | — |
| Oriel Investigative Site | Houston | Texas | 77099 | — |
| Oriel Investigative Site | Plano | Texas | 75093 | — |
| Oriel Investigative Site | Richmond | Virginia | 23229 | — |
| Oriel Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02260492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02260492 live on ClinicalTrials.gov.